Gain Therapeutics, Inc. (GANX)

NASDAQ: GANX · Real-Time Price · USD

1.750

-0.070 (-3.85%)

At close: May 15, 2026, 4:00 PM EDT

1.780

+0.030 (1.71%)

After-hours: May 15, 2026, 7:56 PM EDT

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Research and Development in The Pharmaceutical Sector	55.18K	132.64K	133.93K
Research and Development in The Pharmaceutical Sector Growth	-58.40%	-0.96%	-
Total	55.18K	132.64K	133.93K
Total Growth	-58.40%	-0.96%	-

Source: S&P Global Market Intelligence.